scispace - formally typeset
Search or ask a question
Institution

University of Milan

EducationMilan, Italy
About: University of Milan is a education organization based out in Milan, Italy. It is known for research contribution in the topics: Population & Transplantation. The organization has 58413 authors who have published 139784 publications receiving 4636354 citations. The organization is also known as: Università degli Studi di Milano & Statale.


Papers
More filters
Journal ArticleDOI
TL;DR: A recently developed approach to formalize the analysis of extended architectures by successive simplifications of a crystal structure perceived as a periodic net is discussed and the up-to-date methods for prediction of the topology of underlying nets are discussed.
Abstract: We discuss a recently developed approach to formalize the analysis of extended architectures by successive simplifications of a crystal structure perceived as a periodic net. The approach has been implemented into the program package TOPOS that allows one to simplify and classify coordination polymers of any complexity in an automated mode. Using TOPOS, we retrieved 6620 3-periodic coordination polymers from the Cambridge Structural Database and represented them in a standard way as underlying nets. The topological classification of both 975 interpenetrating and 5645 single 3-periodic underlying nets has been performed and compared. The up-to-date methods for prediction of the topology of underlying nets are discussed and the ways to develop reticular chemistry are outlined.

600 citations

Journal ArticleDOI
04 Aug 2000-Science
TL;DR: The identified two heterozygous missense mutations in the nuclear gene encoding the heart/skeletal muscle isoform of the adenine nucleotide translocator (ANT1) in five families and one sporadic patient indicate that ANT has a role in mtDNA maintenance and that a mitochondrial disease can be caused by a dominant mechanism.
Abstract: Autosomal dominant progressive external ophthalmoplegia is a rare human disease that shows a Mendelian inheritance pattern, but is characterized by large-scale mitochondrial DNA (mtDNA) deletions. We have identified two heterozygous missense mutations in the nuclear gene encoding the heart/skeletal muscle isoform of the adenine nucleotide translocator (ANT1) in five families and one sporadic patient. The familial mutation substitutes a proline for a highly conserved alanine at position 114 in the ANT1 protein. The analogous mutation in yeast caused a respiratory defect. These results indicate that ANT has a role in mtDNA maintenance and that a mitochondrial disease can be caused by a dominant mechanism.

600 citations

Journal ArticleDOI
TL;DR: This paper aims to demonstrate the importance of knowing the carrier and removal status of canine coronavirus, as a source of infection for other animals, not necessarily belonging to the same breeds.
Abstract: ABPMambulatory blood pressure monitoringACEangiotensin converting enzymeARBangiotensin receptor blockerA-Vatrio-ventricularBBbeta-blockerBPblood pressureCHDcoronary heart diseaseCKDchronic kidney d...

599 citations

Journal ArticleDOI
TL;DR: In this paper, the authors investigated whether these alterations involve sympathetic drive in 10 young obese sub-groups and found that the sympathetic drive was not involved in the majority of the cases.
Abstract: Human obesity is characterized by profound alterations in the hemodynamic and metabolic states. Whether these alterations involve sympathetic drive is controversial. In 10 young obese subj...

597 citations

Journal ArticleDOI
TL;DR: Entrectinib was shown to be well tolerated and active against those gene fusions in solid tumors, including in patients with primary or secondary CNS disease, and a complete CNS response was achieved in a patient with SQSTM1-NTRK1-rearranged lung cancer.
Abstract: Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or metastatic solid tumors, including patients with active central nervous system (CNS) disease. Here, we summarize the overall safety and report the antitumor activity of entrectinib in a cohort of patients with tumors harboring NTRK1/2/3, ROS1, or ALK gene fusions, naive to prior TKI treatment targeting the specific gene, and who were treated at doses that achieved therapeutic exposures consistent with the recommended phase II dose. Entrectinib was well tolerated, with predominantly Grades 1/2 adverse events that were reversible with dose modification. Responses were observed in non-small cell lung cancer, colorectal cancer, mammary analogue secretory carcinoma, melanoma, and renal cell carcinoma, as early as 4 weeks after starting treatment and lasting as long as >2 years. Notably, a complete CNS response was achieved in a patient with SQSTM1-NTRK1-rearranged lung cancer.Significance: Gene fusions of NTRK1/2/3, ROS1, and ALK (encoding TRKA/B/C, ROS1, and ALK, respectively) lead to constitutive activation of oncogenic pathways. Entrectinib was shown to be well tolerated and active against those gene fusions in solid tumors, including in patients with primary or secondary CNS disease. Cancer Discov; 7(4); 400-9. ©2017 AACR.This article is highlighted in the In This Issue feature, p. 339.

597 citations


Authors

Showing all 58902 results

NameH-indexPapersCitations
Yi Cui2201015199725
Peter J. Barnes1941530166618
Thomas C. Südhof191653118007
Charles A. Dinarello1901058139668
Alberto Mantovani1831397163826
John J.V. McMurray1781389184502
Giuseppe Remuzzi1721226160440
Russel J. Reiter1691646121010
Jean Louis Vincent1611667163721
Tobin J. Marks1591621111604
Tomas Hökfelt158103395979
José Baselga156707122498
Naveed Sattar1551326116368
Silvia Franceschi1551340112504
Frederik Barkhof1541449104982
Network Information
Related Institutions (5)
Sapienza University of Rome
155.4K papers, 4.3M citations

97% related

University of Padua
114.8K papers, 3.6M citations

97% related

University of Bologna
115.1K papers, 3.4M citations

97% related

Utrecht University
139.3K papers, 6.2M citations

94% related

Radboud University Nijmegen
83K papers, 3.2M citations

94% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023240
2022777
20219,390
20209,000
20197,475
20186,804